
OSE Immunotherapeutics SA
PAR:OSE

OSE Immunotherapeutics SA?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4.615
10.74
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does OSE Immunotherapeutics SA hold over its rivals?
What risks and challenges
does OSE Immunotherapeutics SA face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of OSE Immunotherapeutics SA.
Provide an overview of the primary business activities
of OSE Immunotherapeutics SA.
What unique competitive advantages
does OSE Immunotherapeutics SA hold over its rivals?
What risks and challenges
does OSE Immunotherapeutics SA face in the near future?
Has there been any significant insider trading activity
in OSE Immunotherapeutics SA recently?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for OSE Immunotherapeutics SA.
Provide P/S
for OSE Immunotherapeutics SA.
Provide P/E
for OSE Immunotherapeutics SA.
Provide P/OCF
for OSE Immunotherapeutics SA.
Provide P/FCFE
for OSE Immunotherapeutics SA.
Provide P/B
for OSE Immunotherapeutics SA.
Provide EV/S
for OSE Immunotherapeutics SA.
Provide EV/GP
for OSE Immunotherapeutics SA.
Provide EV/EBITDA
for OSE Immunotherapeutics SA.
Provide EV/EBIT
for OSE Immunotherapeutics SA.
Provide EV/OCF
for OSE Immunotherapeutics SA.
Provide EV/FCFF
for OSE Immunotherapeutics SA.
Provide EV/IC
for OSE Immunotherapeutics SA.
Show me price targets
for OSE Immunotherapeutics SA made by professional analysts.
What are the Revenue projections
for OSE Immunotherapeutics SA?
How accurate were the past Revenue estimates
for OSE Immunotherapeutics SA?
What are the Net Income projections
for OSE Immunotherapeutics SA?
How accurate were the past Net Income estimates
for OSE Immunotherapeutics SA?
What are the EPS projections
for OSE Immunotherapeutics SA?
How accurate were the past EPS estimates
for OSE Immunotherapeutics SA?
What are the EBIT projections
for OSE Immunotherapeutics SA?
How accurate were the past EBIT estimates
for OSE Immunotherapeutics SA?
Compare the revenue forecasts
for OSE Immunotherapeutics SA with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of OSE Immunotherapeutics SA and its key competitors using the latest financial data.
Compare historical revenue growth rates
of OSE Immunotherapeutics SA against its competitors.
Analyze the profit margins
(gross, operating, and net) of OSE Immunotherapeutics SA compared to its peers.
Compare the P/E ratios
of OSE Immunotherapeutics SA against its peers.
Discuss the investment returns and shareholder value creation
comparing OSE Immunotherapeutics SA with its peers.
Analyze the financial leverage
of OSE Immunotherapeutics SA compared to its main competitors.
Show all profitability ratios
for OSE Immunotherapeutics SA.
Provide ROE
for OSE Immunotherapeutics SA.
Provide ROA
for OSE Immunotherapeutics SA.
Provide ROIC
for OSE Immunotherapeutics SA.
Provide ROCE
for OSE Immunotherapeutics SA.
Provide Gross Margin
for OSE Immunotherapeutics SA.
Provide Operating Margin
for OSE Immunotherapeutics SA.
Provide Net Margin
for OSE Immunotherapeutics SA.
Provide FCF Margin
for OSE Immunotherapeutics SA.
Show all solvency ratios
for OSE Immunotherapeutics SA.
Provide D/E Ratio
for OSE Immunotherapeutics SA.
Provide D/A Ratio
for OSE Immunotherapeutics SA.
Provide Interest Coverage Ratio
for OSE Immunotherapeutics SA.
Provide Altman Z-Score Ratio
for OSE Immunotherapeutics SA.
Provide Quick Ratio
for OSE Immunotherapeutics SA.
Provide Current Ratio
for OSE Immunotherapeutics SA.
Provide Cash Ratio
for OSE Immunotherapeutics SA.
What is the historical Revenue growth
over the last 5 years for OSE Immunotherapeutics SA?
What is the historical Net Income growth
over the last 5 years for OSE Immunotherapeutics SA?
What is the current Free Cash Flow
of OSE Immunotherapeutics SA?
Discuss the annual earnings per share (EPS)
trend over the past five years for OSE Immunotherapeutics SA.
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
FR |
![]() |
OSE Immunotherapeutics SA
PAR:OSE
|
140.2m EUR | 1.7 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
6T USD | 36 547 712.8 |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
374.2B USD | 6.6 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
169.1B USD | 5.1 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
131.9B USD | 4.6 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
131.1B USD | 11.9 |
|
US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 1 927.6 |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
123.2B AUD | 5.1 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
72.6B USD | 5.1 |
|
US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 18.6 |
|
NL |
![]() |
argenx SE
XBRU:ARGX
|
34B EUR | 16.8 |
|
Revenue Growth | P/S to Growth | |||||
---|---|---|---|---|---|---|
FR |
![]() |
OSE Immunotherapeutics SA
PAR:OSE
|
Average P/S:
3 322 701.4
1.7
|
148%
|
0 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
36 547 712.8
|
N/A | N/A |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
6.6
|
8%
|
0.8 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
5.1
|
4%
|
1.3 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
4.6
|
3%
|
1.5 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
11.9
|
10%
|
1.2 |
|
US |
E
|
Epizyme Inc
F:EPE
|
1 927.6
|
N/A | N/A |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
5.1
|
7%
|
0.7 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
5.1
|
7%
|
0.7 |
|
US |
S
|
Seagen Inc
F:SGT
|
18.6
|
30%
|
0.6 |
|
NL |
![]() |
argenx SE
XBRU:ARGX
|
16.8
|
37%
|
0.5 |
|
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.